Lara Hathout, MD

Radiation Oncology has been a passion of mine from my first year in medical school. My first clinical rotation was an elective in radiation oncology that changed my perspective on cancer care. I witnessed firsthand the importance of patient-focused care, with empathy and bedside manner that guided and fueled my continued interest in this field of medicine. My primary goal as a radiation oncologist is to deliver treatment with cutting-edge technology while minimizing side effects and tailoring the treatment to the patients’ needs.

I am a Board Certified radiation oncologist in the Department of Radiation Oncology at the Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School. I completed my Brachytherapy Fellowship at the Memorial Sloan-Kettering Cancer Center in June 2014 after completing my medical training and a residency in Radiation Oncology at University of Montreal in Montreal, Canada.

Prior to joining Rutgers Cancer Institute, I served as a Clinical Instructor of Radiation Oncology at the Université de Laval at Centre Hospitalier Universitaire de Québec in Quebec City, Canada. My specialization is in Gynecologic, gastro-intestinal and genitourinary cancers.

I offer patients state-of-the-art treatment with leading edge technologies through my expertise in Brachytherapy, Intensity Modulated radiation therapy (IMRT), Stereotactic Body radiotherapy (SBRT) and Proton Beam Therapy. In addition to English I speak several languages fluently including French.

In addition to my clinical practice I continue to be active in grant submissions with a focus on the integration of modern imaging and treatment techniques in the management of genitourinary and gynecologic cancers. As a peer reviewer for the Brachytherapy Journal, Journal of Contemporary Brachytherapy, American Brachytherapy Society and American Society of Therapeutic Radiation Oncology I am committed to publishing and educating both my peers and patients in treatment options while guiding them to make informed decisions on continuing care.